LIVE
LIVE GMP
Shellz India Ltd₹+17·Tonbo Imaging India Ltd₹+520·Zetwerk Manufacturing Business Ltd₹+8·Bonfiglioli Transmissions Ltd₹+131·Sahajanand Medical Technologies Ltd₹+28·Jio Platforms Ltd₹+220·Paras Healthcare Ltd₹+95·Ravita Engineering Services Ltd₹+3·Fusion CX Ltd₹+5·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·Shellz India Ltd₹+17·Tonbo Imaging India Ltd₹+520·Zetwerk Manufacturing Business Ltd₹+8·Bonfiglioli Transmissions Ltd₹+131·Sahajanand Medical Technologies Ltd₹+28·Jio Platforms Ltd₹+220·Paras Healthcare Ltd₹+95·Ravita Engineering Services Ltd₹+3·Fusion CX Ltd₹+5·HD Fire Protect Ltd₹+80·Vaibhav Vyapaar Ltd₹0·R.K.Fashion Accessories Ltd₹0·Vishal Nirmiti Ltd₹+8·Nityas Gems & Jewellery Ltd₹+1·Paramount Syntex Ltd₹0·Acme India Industries Ltd₹+47·TNA Solutions Ltd₹+10·
Jindal Supreme (India) Ltd
CLOSED
NSE & BSE
Bookbuilding IPO
Fresh capital cum OFS
Jindal Supreme (India) IPO GMP
GREY MARKET
PREMIUM
₹
+ 26
+28% expected return
EST. LISTING
PRICE
₹119
Issue Price: ₹
93
Issue Price
₹93
Face Value
₹10
Lot Size
161 shares
IPO Size
Agg. upto ₹125 Cr
Open Date
16 Sep 2026
Close Date
18 Sep 2026
Allotment
21 Sep 2026
Listing Date
23 Sep 2026
Exchange
NSE & BSE
Jindal Supreme (India) IPO Details: Price, Dates & Financials
The Jindal Supreme (India) IPO GMP strength score is 7.2 out of 10, which the dashboard rates as Good. The Jindal Supreme (India) IPO valuation is tagged Strong. The Jindal Supreme (India) IPO is subscribed 126.05 times overall so far. Amounts are calculated at the upper price band of ₹93.
IPO Analytics Dashboard
LIVE
Jindal Supreme (India) IPO GMP Insights
Valuation
Strong
Jindal Supreme (India) IPO GMP Strength Score
7
/ 10
Good
0–3 Weak
3–6 Moderate
6–8 Good
8–10 Strong
Jindal Supreme (India) IPO Category-wise Subscription
Shares offered, bid & amount
| Category | Sub (x) | Offered | Bid For |
|---|---|---|---|
| QIB | 51.05 | 6,714,000 | 342,737,283 |
| NII / HNI | 330.27 | 2,014,200 | 665,238,315 |
| Retail (RII) | 145.68 | 4,699,800 | 684,680,353 |
| Total | 126.05 | 13,428,000 | 1,692,655,951 |
* Amount calculated at upper price band (₹93) · ** Total includes all investor categories
Jindal Supreme (India) IPO Application Sizing
Minimum investment by category
Retail Investors ?
Min. Lots
1
Shares / Lot
161
Min. Investment
₹14,973
Jindal Supreme (India) IPO Valuation — EPS & P/E
Pre & post-issue metrics
Pre-Issue EPS ?
₹ 6
Post-Issue EPS ?
₹ 6
Pre-Issue P/E ?
17 x
Post-Issue P/E ?
14 x
Jindal Supreme (India) IPO Timeline & Key Dates
- 1 Initiation of Refund 22 Sep 2026
- 2 Credit of Shares to Demat 22 Sep 2026
- 3 Lock-in Period (30%) Wed, Oct 21, 2026
- 4 Lock-in Period (50%) Sun, Dec 20, 2026
Investor Interpretation
- The IPO P/E of 14x reflects a strong valuation relative to typical market ranges.
- Pre-issue EPS of ₹6 compares to post-issue EPS of ₹6 after dilution.
This IPO shows moderate investor interest. Review financial details and compare valuation with industry peers before investing.
Jindal Supreme (India) IPO Subscription FAQs
Jindal Supreme (India) IPO is subscribed 126.05x overall (Retail 145.68x, QIB 51.05x, NII/HNI 330.27x).
The retail (RII) portion of Jindal Supreme (India) IPO is subscribed 145.68x.
Jindal Supreme (India) IPO — QIB 51.05x, NII/HNI 330.27x.
In Jindal Supreme (India) IPO, retail investors can apply for a minimum of 1 lot(s) (₹₹14,973).
Shares offered by category — QIB 6,714,000 shares, Retail 4,699,800 shares.
Jindal Supreme (India) IPO valuation — pre-issue EPS ₹5.59, post-issue EPS ₹6.49, pre-issue P/E 16.64, post-issue P/E 14.33.
30% lock-in period ends: Wed, Oct 21, 2026. 50% lock-in period ends: Sun, Dec 20, 2026.
Subscription is shares bid for divided by shares offered in that category. If 10 lakh shares are offered and 50 lakh are bid for, the category is subscribed 5 times. Final numbers are confirmed after the bidding closes.
GMP and IPO data are unofficial and for information only — not investment advice. Read the full disclaimer.